Preimplantation Genetic Testing (PGT) is an embryonic procedure done in unison with IVF where a tissue biopsy of a developing embryo is taken and tested for genetic (ab)normalities. The tissue biopsy takes place on blastocysts stage embryos. After which, the tissue is sent to a third-party genetics lab for analysis.
PGT is broken into 3 main testing categories: Preimplantation genetic testing for aneuploidies (PGT-A), monogenic/single gene defects (PGT-M), and chromosomal structural rearrangements (PGT-SR)
Formerly known as PGS (preimplantation genetic screening), PGT-A gives information about the number of chromosomes within IVF embryos. Those with normal results have higher odds of achieving a successful pregnancy. It is also often used to choose the sex of the anticipated child.
PGT-M is performed on blastocyst stage embryos to significantly reduce the risk of having a child with a specific genetic disease. Whether you have a genetic disorder or have learned of a risk status through screening, an affected family member, a pregnancy, or a child with a known single-gene disorder, PGTM may be the solution foryour family-building needs.
PGT-SR is for people who have a chromosome rearrangement and should thus be considered in conjunction with IVF if you had a child or pregnancy with a chromosome rearrangement or if you or your partner is a carrier of translocations.
Any PGT cycle eliminates the ability to do a fresh embryo transfer. For PGT-M and PGT-SR, we need approval from CooperGenomics, our testing company, prior to starting your IVF cycle. Results can take 2-4 weeks depending on the type of PGT you plan to do. Cost will also vary with CooperGenomics.